Scientist Home Future Health Limited (SHFH) Fair Value 2026

SHFH · Pharmaceutical Retailers ·

By CirclFi Research Team · Data from SEC EDGAR, FRED & GDELT

Quality Score

5.6 /10

32 fundamental signals · 0 models active

Value Trap Risk

SAFE (0/100)

Quick Summary — As of 2026-08-27, Scientist Home Future Health Limited (SHFH) trades at $7.90. QOC: 5.6/10. Value Trap Risk: 0/100 (SAFE). 0/13 models active.

Key Facts

Ticker
SHFH
Price
$7.90
Quality Score
5.6/10
Value Trap Risk
0/100
Models Active
0/13
Last Updated
Strength: 0 independent models provide multi-angle coverage
Risk: Limited model coverage (0/13) may reduce confidence

What Fair Value Does Each Model Give SHFH?

0 Intrinsic Value Models vs. Current Price ($7.90)

Core Models (Unlocked)
Model Fair Value Upside

All Models Active

All 0 models are displayed above.

What Is Scientist Home Future Health Limited (SHFH) Worth in 2026?

According to the CirclFi Deep Alpha Valuation Engine, Scientist Home Future Health Limited currently lacks sufficient data across our 13-model framework. As more financial data is processed from SEC filings, our models will generate intrinsic value estimates.

What Do the Models Say About SHFH?

0 of 13 models are currently active for SHFH. See which stocks rank higher →

How Does SHFH Rank in Pharmaceutical Retailers?

Among 9 Pharmaceutical Retailers stocks, SHFH ranks #4 by Quality of Company score. CirclFi's QOC score of 5.6/10 evaluates 32 fundamental signals. A score of 5.6 reflects mixed fundamentals.

As a pharmaceutical industry, Scientist Home Future Health Limited operates in a sector where clinical trial success rate is a critical driver of valuation. Investors evaluating SHFH should weigh these sector-specific dynamics alongside our model-derived fair values.

Is SHFH a Value Trap?

CirclFi's Value Trap algorithm assigns SHFH a score of 0/100 (SAFE). This indicates minimal risk. Fundamentals are healthy. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →

Multi-Model Methodology

0 of 13 models are active for Scientist Home Future Health Limited. Limited activation may indicate insufficient history. Each model applies a fundamentally different valuation philosophy. See the complete methodology →

According to the CirclFi 32-factor quality framework, Scientist Home Future Health Limited's fundamental quality profile registers 5.6/10. This respectable score captures the company's profitability depth, growth consistency, balance sheet resilience, and shareholder return track record.

CirclFi runs 13 independent models for each stock. Browse all stocks with 13-model coverage →

Data Sources & Confidence

Every SHFH valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →

CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →

This analysis is produced by the CirclFi Valuation Engine using quantitative models applied to SEC EDGAR filings, public market feeds, and FRED macroeconomic indicators. It is not financial advice.

Read the full investment analysis: Should You Buy Scientist Home Future Health Limited Stock in 2026? →

Bull case, bear case, risk factors & peer comparison — updated daily

Which Similar Pharmaceutical Retailers Stocks Should You Also Analyze?

8 related Pharmaceutical Retailers stocks with 13-model coverage

Read investment analysis: BHIC · PETS · HITI · DHTI · SCNX · PMHS · POM · RDGT

Which Other Stocks Have a Similar Quality Score to SHFH?

7 companies across all industries closest to SHFH’s Quality of Company score of 5.6/10.

Read investment analysis: QUCY · W · VNOV · DDC · STLN · KYNB · NVDA

What Else Do Investors Ask About Scientist Home Future Health Limited’s Valuation?

What is Scientist Home Future Health Limited's intrinsic value in 2026?

CirclFi does not yet have enough active models to publish a median fair value for Scientist Home Future Health Limited (SHFH). The Quality of Company score is 5.6/10 across 32 fundamental signals. All models use SEC EDGAR filings updated daily. See our methodology page for how each model works.

Is SHFH overvalued or undervalued right now?

At $7.90, 0 of 0 active models suggest SHFH may be undervalued, while 0 indicate potential overvaluation. The assessment depends on which methodology best fits Scientist Home Future Health Limited's business model in Pharmaceutical Retailers.

What does a Quality of Company score of 5.6 mean for SHFH?

Scientist Home Future Health Limited's QOC of 5.6/10 reflects 32 fundamental signals: profitability margins, revenue growth consistency, balance sheet leverage, free cash flow generation, and capital allocation efficiency. Scores between 5-7 reflect moderate fundamentals with areas for improvement.

How many valuation models does CirclFi run on SHFH?

CirclFi analyzes SHFH with 13 institutional-grade models daily: Bayesian DCF (Monte Carlo + jump-diffusion), EPV (Greenwald zero-growth), EROIC Spread (McKinsey reinvestment), First Chicago (3-scenario), Markov DDM (regime-switching), ML-RIV (machine learning residual income), Dynamic NAV (asset-based), PWERM (option-theoretic), Regime Cross-Sectional (relative), Sentiment SOTP (hybrid), CUCE Ensemble (meta-model), FTNN Topology (neural network), and RCMH-DCF (conditional regime). Currently 0 of 13 are active for this stock. Read the full methodology →

Is SHFH a value trap in 2026?

Scientist Home Future Health Limited's Value Trap score is 0/100 (SAFE). This low score indicates the current valuation is not artificially depressed by fundamental deterioration, suggesting genuine opportunity rather than a trap. Browse stocks by value-trap risk →

Cite this analysis — “CirclFi assigns Scientist Home Future Health Limited (SHFH) a Quality of Company score of 5.6/10 across 32 fundamental signals as of 2026-08-27.” Source: circlfi.com/stock/SHFH/ · Methodology
Primary sources for this SHFH valuation

Market data for SHFH as of ; valuations recomputed .